Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C11H18NO9.Na |
| Molecular Weight | 331.2517 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].CC(=O)N[C@@H]1[C@@H](O)C[C@](O)(O[C@H]1[C@H](O)[C@H](O)CO)C([O-])=O
InChI
InChIKey=QKFTYFYIYXTFBX-BKSOAOGQSA-M
InChI=1S/C11H19NO9.Na/c1-4(14)12-7-5(15)2-11(20,10(18)19)21-9(7)8(17)6(16)3-13;/h5-9,13,15-17,20H,2-3H2,1H3,(H,12,14)(H,18,19);/q;+1/p-1/t5-,6+,7+,8+,9+,11-;/m0./s1
| Molecular Formula | Na |
| Molecular Weight | 22.98976928 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C11H18NO9 |
| Molecular Weight | 308.2619 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Sodium aceneuramate is a sodium salt of aceneuramic acid (sialic acid). It is an effective inhalant expectorant. Inhalation of sodium aceneuramate repaired inflammation in the airway, and caused bronchitic rabbits to produce sputa with a low viscosity, similar to normal air-way secretions. Sodium aceneuramate protected the mucociliary transport impaired bycigarette smoke in a dose-dependent manner. The results suggest that sodium aceneuramate may participate in the defense mechanism in the airway against irritant gases. Sodium aceneuramate inhibited bronchial anaphylaxis and the release of histamine into bronchoalveolar lavages. Sodium aceneuramate has an action which elevates the viscoelasticity of secretions in the respiratory tract.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9551758
Sodium aceneuramate was administered at 2 mg, b.i.d. for 7 days by inhalation to ten patients with bronchiectasis, chronicbronchitis, diffuse panbronchiolitis and other respiratorydiseases that cause sputa.
Route of Administration:
Respiratory
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:42:56 GMT 2025
by
admin
on
Mon Mar 31 21:42:56 GMT 2025
|
| Record UNII |
C4WSL8GQZ2
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
92413-99-5
Created by
admin on Mon Mar 31 21:42:56 GMT 2025 , Edited by admin on Mon Mar 31 21:42:56 GMT 2025
|
PRIMARY | |||
|
DTXSID601032359
Created by
admin on Mon Mar 31 21:42:56 GMT 2025 , Edited by admin on Mon Mar 31 21:42:56 GMT 2025
|
PRIMARY | |||
|
23662231
Created by
admin on Mon Mar 31 21:42:56 GMT 2025 , Edited by admin on Mon Mar 31 21:42:56 GMT 2025
|
PRIMARY | |||
|
C4WSL8GQZ2
Created by
admin on Mon Mar 31 21:42:56 GMT 2025 , Edited by admin on Mon Mar 31 21:42:56 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |